-
Mashup Score: 0
Dupilumab’s efficacy was sustained through the 260-week open-label study.
Source: www.dermatologytimes.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Fall 2023 American Academy of Dermatology Virtual Career Summit - 5 month(s) ago
The AAD Virtual Career Summit is an online event bringing together Dermatology professionals and industry experts for a day of live sessions, networking, and connecting with recruiters nationwide.
Source: app.brazenconnect.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0
AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
Source: www.jaad.orgCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0FDA Approves Bimekizumab for Moderate to Severe Plaque Psoriasis - 5 month(s) ago
Bimekizumab is now the first and only approved IL-17A and IL-17F inhibitor for this indication.
Source: www.dermatologytimes.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 1Strategies to Improve Psychological Health Outcomes in Children with Atopic Dermatitis - 5 month(s) ago
Caregivers of children with AD also experience increased levels of stress, anxiety, depression, and suicidal ideation, extending the impact beyond the affected individual to their families.
Source: www.dermatologytimes.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Home - 5 month(s) ago
The 2nd International Congress on ATTR Amyloidosis (ICAA) will explore the disease state, diagnosis, and the latest advancements and treatments in the management of amyloidosis. This conference is an opportunity to gain knowledge on new developments in this complex disease. Leading experts will present clinically relevant information that you will find immediately useful in the care of your patients. It is our pleasure and privilege to welcome you to the 2nd Biennial International Congress on ATTR Amyloidos
Source: na.eventscloud.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Given Prevalence, Study Underscores Need for Education Surrounding Pediatric Dermatoses in Patients With Skin of Color - 5 month(s) ago
In studying pediatric patients with skin of color in a center specializing in pigment and skin of color, investigators described a paucity of literature of such nature.
Source: www.dermatologytimes.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Patient Case #1: AD Treatment Approaches - 5 month(s) ago
Elizabeth Swanson, MD, and Brad Glick, DO, MPH, FAOCD, share treatment approaches for pediatric patients with AD.
Source: www.dermatologytimes.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 2
Severe psoriasis is associated with an increased cardiovascular risk, which may be independent of the traditional risk factors. Coronary microvascular…
Source: www.sciencedirect.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Incyte Announces Expanded TRuE-AD3 Data at EADV - 5 month(s) ago
The expanded study data correlates with the safety and efficacy of ruxolitinib cream in patients with atopic dermatitis.
Source: www.dermatologytimes.comCategories: Dermatology, Latest HeadlinesTweet
According to study authors, topical therapies are often insufficient for controlling moderate to severe #AtopicDermatitis. A 5-year open-label study reaffirmed the long-term efficacy and safety of #dupilumab in adult patients with moderate to severe AD. https://t.co/sa3EOnuQIA